Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 13 | 2022 | 251 | 3.330 |
Why?
|
| Endovascular Procedures | 23 | 2022 | 609 | 2.960 |
Why?
|
| Blood Vessel Prosthesis Implantation | 16 | 2022 | 297 | 2.430 |
Why?
|
| Fee-for-Service Plans | 5 | 2020 | 66 | 1.810 |
Why?
|
| Clinical Coding | 4 | 2018 | 44 | 1.750 |
Why?
|
| Aortic Aneurysm, Abdominal | 12 | 2022 | 236 | 1.460 |
Why?
|
| Surgeons | 5 | 2020 | 161 | 1.400 |
Why?
|
| Relative Value Scales | 2 | 2020 | 16 | 1.220 |
Why?
|
| Diagnosis-Related Groups | 2 | 2018 | 86 | 1.140 |
Why?
|
| Physician's Role | 2 | 2018 | 120 | 1.040 |
Why?
|
| Quality Indicators, Health Care | 5 | 2020 | 332 | 0.980 |
Why?
|
| Endarterectomy, Carotid | 2 | 2022 | 91 | 0.900 |
Why?
|
| Peripheral Arterial Disease | 5 | 2020 | 164 | 0.880 |
Why?
|
| Patient Care | 1 | 2024 | 78 | 0.850 |
Why?
|
| Medicare | 4 | 2022 | 601 | 0.850 |
Why?
|
| Blood Vessel Prosthesis | 10 | 2022 | 215 | 0.850 |
Why?
|
| Aortic Aneurysm | 3 | 2021 | 81 | 0.840 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2020 | 43 | 0.820 |
Why?
|
| Lower Extremity | 4 | 2023 | 153 | 0.780 |
Why?
|
| Retrospective Studies | 26 | 2023 | 6088 | 0.740 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 100 | 0.720 |
Why?
|
| Health Facilities | 1 | 2020 | 41 | 0.710 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 57 | 0.700 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 16 | 0.690 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 43 | 0.690 |
Why?
|
| Hospital Costs | 2 | 2020 | 119 | 0.680 |
Why?
|
| Postoperative Complications | 10 | 2021 | 1203 | 0.680 |
Why?
|
| Documentation | 2 | 2018 | 127 | 0.670 |
Why?
|
| Data Accuracy | 2 | 2018 | 28 | 0.660 |
Why?
|
| Leadership | 2 | 2018 | 195 | 0.600 |
Why?
|
| Forms and Records Control | 1 | 2018 | 14 | 0.600 |
Why?
|
| Databases, Factual | 12 | 2021 | 814 | 0.580 |
Why?
|
| Medical Records | 1 | 2018 | 133 | 0.580 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2021 | 105 | 0.570 |
Why?
|
| Treatment Outcome | 22 | 2022 | 5280 | 0.570 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 131 | 0.560 |
Why?
|
| Contracts | 1 | 2017 | 8 | 0.560 |
Why?
|
| Negotiating | 1 | 2017 | 14 | 0.550 |
Why?
|
| Physicians | 1 | 2022 | 440 | 0.550 |
Why?
|
| Time Factors | 19 | 2021 | 3615 | 0.510 |
Why?
|
| Quality Improvement | 4 | 2020 | 418 | 0.510 |
Why?
|
| Axillary Artery | 1 | 2015 | 7 | 0.500 |
Why?
|
| Aged, 80 and over | 19 | 2021 | 5137 | 0.500 |
Why?
|
| Breast Neoplasms, Male | 1 | 2015 | 14 | 0.500 |
Why?
|
| Subclavian Artery | 1 | 2015 | 24 | 0.500 |
Why?
|
| Vascular System Injuries | 1 | 2015 | 20 | 0.490 |
Why?
|
| Terminology as Topic | 1 | 2016 | 133 | 0.480 |
Why?
|
| Radiation Injuries | 1 | 2015 | 62 | 0.480 |
Why?
|
| Aneurysm | 1 | 2015 | 56 | 0.470 |
Why?
|
| Humans | 41 | 2024 | 59395 | 0.470 |
Why?
|
| Ischemia | 2 | 2018 | 199 | 0.460 |
Why?
|
| Health Care Costs | 4 | 2020 | 202 | 0.460 |
Why?
|
| United States | 11 | 2024 | 7424 | 0.450 |
Why?
|
| Computed Tomography Angiography | 4 | 2019 | 110 | 0.450 |
Why?
|
| Patient Care Team | 2 | 2016 | 327 | 0.450 |
Why?
|
| Medical Audit | 1 | 2014 | 58 | 0.440 |
Why?
|
| Aged | 24 | 2023 | 13421 | 0.420 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2019 | 49 | 0.420 |
Why?
|
| Appendectomy | 2 | 2021 | 49 | 0.390 |
Why?
|
| Self Report | 1 | 2014 | 359 | 0.370 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2022 | 42 | 0.370 |
Why?
|
| Cost Control | 1 | 2010 | 24 | 0.350 |
Why?
|
| Aortic Rupture | 3 | 2016 | 54 | 0.350 |
Why?
|
| Vascular Patency | 6 | 2021 | 135 | 0.340 |
Why?
|
| Prosthesis Design | 9 | 2022 | 209 | 0.330 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 203 | 0.330 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2021 | 396 | 0.320 |
Why?
|
| Massachusetts | 7 | 2020 | 2019 | 0.320 |
Why?
|
| Cost-Benefit Analysis | 3 | 2020 | 297 | 0.310 |
Why?
|
| Stents | 3 | 2021 | 461 | 0.310 |
Why?
|
| Length of Stay | 4 | 2021 | 776 | 0.300 |
Why?
|
| Male | 26 | 2023 | 27760 | 0.300 |
Why?
|
| Education, Medical, Graduate | 4 | 2021 | 317 | 0.290 |
Why?
|
| Risk Factors | 14 | 2022 | 4985 | 0.280 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2018 | 692 | 0.280 |
Why?
|
| Chi-Square Distribution | 6 | 2016 | 409 | 0.280 |
Why?
|
| Internship and Residency | 3 | 2021 | 747 | 0.270 |
Why?
|
| Comorbidity | 5 | 2018 | 1078 | 0.260 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2021 | 62 | 0.260 |
Why?
|
| Female | 25 | 2023 | 30736 | 0.250 |
Why?
|
| Carotid Stenosis | 2 | 2019 | 104 | 0.250 |
Why?
|
| Aortography | 3 | 2022 | 55 | 0.250 |
Why?
|
| Reoperation | 2 | 2018 | 272 | 0.240 |
Why?
|
| Aortic Diseases | 2 | 2016 | 72 | 0.230 |
Why?
|
| Hospital Mortality | 3 | 2020 | 842 | 0.230 |
Why?
|
| Aorta, Abdominal | 2 | 2022 | 58 | 0.230 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 1022 | 0.230 |
Why?
|
| Risk Assessment | 8 | 2023 | 1925 | 0.220 |
Why?
|
| Workload | 2 | 2021 | 118 | 0.210 |
Why?
|
| Middle Aged | 14 | 2023 | 16324 | 0.210 |
Why?
|
| Angioplasty | 1 | 2022 | 51 | 0.200 |
Why?
|
| Natural Language Processing | 1 | 2022 | 47 | 0.200 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 674 | 0.190 |
Why?
|
| Walking | 1 | 2023 | 228 | 0.180 |
Why?
|
| Practice Management | 1 | 2020 | 2 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2022 | 3065 | 0.180 |
Why?
|
| Reimbursement, Incentive | 1 | 2020 | 28 | 0.170 |
Why?
|
| Postoperative Care | 1 | 2020 | 114 | 0.170 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 137 | 0.170 |
Why?
|
| Celiac Artery | 1 | 2019 | 14 | 0.160 |
Why?
|
| Registries | 5 | 2021 | 799 | 0.160 |
Why?
|
| General Surgery | 1 | 2021 | 191 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 1557 | 0.150 |
Why?
|
| Atherectomy | 1 | 2018 | 12 | 0.150 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 308 | 0.150 |
Why?
|
| Clinical Competence | 3 | 2021 | 683 | 0.150 |
Why?
|
| Survival Rate | 3 | 2021 | 801 | 0.150 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 40 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 132 | 0.140 |
Why?
|
| Intermittent Claudication | 1 | 2018 | 53 | 0.140 |
Why?
|
| Competitive Bidding | 1 | 2017 | 4 | 0.140 |
Why?
|
| Hospital Charges | 1 | 2017 | 23 | 0.140 |
Why?
|
| Device Approval | 1 | 2017 | 13 | 0.140 |
Why?
|
| Laparoscopy | 1 | 2021 | 427 | 0.140 |
Why?
|
| Self-Assessment | 1 | 2017 | 58 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2018 | 187 | 0.130 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 203 | 0.130 |
Why?
|
| Patient Admission | 1 | 2018 | 184 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 85 | 0.130 |
Why?
|
| Endoleak | 3 | 2021 | 39 | 0.130 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 77 | 0.130 |
Why?
|
| Models, Cardiovascular | 1 | 2017 | 76 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 135 | 0.130 |
Why?
|
| Health Expenditures | 1 | 2017 | 116 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 421 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 71 | 0.120 |
Why?
|
| Embolism | 1 | 2016 | 39 | 0.120 |
Why?
|
| Health Status | 1 | 2018 | 426 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2015 | 61 | 0.120 |
Why?
|
| Heart Failure | 2 | 2014 | 853 | 0.120 |
Why?
|
| New York City | 2 | 2011 | 75 | 0.120 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 21 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 725 | 0.120 |
Why?
|
| Limb Salvage | 2 | 2011 | 69 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2017 | 459 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2015 | 189 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2014 | 61 | 0.110 |
Why?
|
| Thrombosis | 1 | 2016 | 182 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2014 | 62 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2014 | 127 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1027 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 110 | 0.100 |
Why?
|
| Critical Illness | 2 | 2018 | 325 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 551 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2014 | 349 | 0.100 |
Why?
|
| Logistic Models | 2 | 2015 | 1234 | 0.100 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 243 | 0.090 |
Why?
|
| Kidney | 1 | 2014 | 413 | 0.090 |
Why?
|
| Pneumonia | 1 | 2014 | 281 | 0.090 |
Why?
|
| Program Evaluation | 3 | 2018 | 470 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 902 | 0.080 |
Why?
|
| Hypertension | 1 | 2014 | 570 | 0.080 |
Why?
|
| Retreatment | 2 | 2019 | 46 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 861 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 228 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 440 | 0.060 |
Why?
|
| Adult | 3 | 2021 | 15696 | 0.050 |
Why?
|
| Patient Selection | 2 | 2016 | 465 | 0.050 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 330 | 0.050 |
Why?
|
| Paraparesis | 1 | 2021 | 9 | 0.050 |
Why?
|
| Renal Artery | 1 | 2021 | 31 | 0.050 |
Why?
|
| Child | 1 | 2010 | 4190 | 0.040 |
Why?
|
| Iliac Artery | 1 | 2021 | 49 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 9 | 0.040 |
Why?
|
| Patient Care Bundles | 1 | 2020 | 11 | 0.040 |
Why?
|
| Appendicitis | 1 | 2021 | 74 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 85 | 0.040 |
Why?
|
| Models, Economic | 1 | 2020 | 43 | 0.040 |
Why?
|
| Cost Savings | 1 | 2020 | 54 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 108 | 0.040 |
Why?
|
| Adolescent | 1 | 2010 | 5857 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 68 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 108 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 205 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 337 | 0.040 |
Why?
|
| Certification | 1 | 2018 | 46 | 0.040 |
Why?
|
| Morbidity | 1 | 2017 | 113 | 0.040 |
Why?
|
| Centralized Hospital Services | 1 | 2017 | 5 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2018 | 278 | 0.030 |
Why?
|
| Regional Health Planning | 1 | 2017 | 10 | 0.030 |
Why?
|
| Hospitals, Low-Volume | 1 | 2017 | 17 | 0.030 |
Why?
|
| Learning Curve | 1 | 2017 | 30 | 0.030 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 32 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 110 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 101 | 0.030 |
Why?
|
| Inservice Training | 1 | 2017 | 81 | 0.030 |
Why?
|
| Embolectomy | 1 | 2016 | 15 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 95 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2016 | 62 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 122 | 0.030 |
Why?
|
| Shock | 1 | 2016 | 31 | 0.030 |
Why?
|
| Vascular Grafting | 1 | 2016 | 39 | 0.030 |
Why?
|
| North America | 1 | 2016 | 105 | 0.030 |
Why?
|
| Educational Status | 1 | 2017 | 264 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 185 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2017 | 212 | 0.030 |
Why?
|
| Health Care Sector | 1 | 2015 | 20 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 37 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 57 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 92 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1480 | 0.030 |
Why?
|
| Acute Disease | 1 | 2016 | 658 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 103 | 0.030 |
Why?
|
| Emergencies | 1 | 2014 | 110 | 0.030 |
Why?
|
| Thrombectomy | 1 | 2016 | 208 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 112 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 2014 | 71 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 203 | 0.030 |
Why?
|
| New England | 1 | 2014 | 267 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 210 | 0.030 |
Why?
|
| Curriculum | 1 | 2017 | 560 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 745 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2338 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2011 | 230 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4290 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2011 | 314 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1118 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2516 | 0.020 |
Why?
|